Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L. Ratner, D. Rauch, H. Abel, B. Caruso, A. Noy, S. K. Barta, S. Parekh, J. C. Ramos, R. Ambinder, A. Phillips, J. Harding, H. H. Baydoun, X. Cheng, S. Jacobson

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma'. Together they form a unique fingerprint.